This is explained by effects of TIMP3 on multiple proteases and receptors, suggesting that its metabolic effects are only in part due to ADAM17 inhibition and posing TIMP3 reconstitution at a more advanced stage as an approach against metabolic diseases compared to ADAM17 inhibition. This evidence concerns the gene TIMP3 and Other metabolic disease.